Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | CGEN | ZNTL | ||
| Company | Cellectis S.A. ADR | Compugen Ltd | Zentalis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.42 | 2.09 | 2.50 | ||
| High | 3.42 | 2.17 | 2.66 | ||
| Low | 3.27 | 2.07 | 2.50 | ||
| Latest | 3.33 | 2.12 | 2.61 | ||
| Change | +0.10 | +0.05 | +0.14 | ||
| % Change | +3.10% | +2.42% | +5.67% | ||
| Volume | 14,485 | 43,967 | 119,501 | ||
| 20-Day Average Volume | 55,515 | 350,792 | 601,915 | ||
| Previous Close | 3.23 | 2.07 | 2.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.58 | 2.12 | 2.57 | ||
| 20-Day Raw Stochastic | 19.57% | 66.67% | 49.51% | ||
| 20-Day Relative Strength | 42.85 | 55.79 | 52.12 | ||
| Weighted Alpha | +80.43 | +40.75 | -29.05 | ||
| Today's Opinion | 56% Sell | 100% Buy | 72% Buy | ||
| Previous Opinion | 56% Sell | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 24% Buy | 96% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.88% since 03/18/26 | -1.38% since 03/18/26 | +3.78% since 03/18/26 | ||
| Low | 3.19 on 03/24/26 | 2.05 on 03/24/26 | 2.40 on 03/24/26 | ||
| High | 3.49 on 03/19/26 | 2.16 on 03/25/26 | 2.70 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | -19.38% since 02/25/26 | +21.59% since 02/25/26 | +5.67% since 02/25/26 | ||
| Low | 3.19 on 03/24/26 | 1.72 on 02/26/26 | 2.10 on 03/06/26 | ||
| High | 4.11 on 02/26/26 | 2.35 on 03/13/26 | 3.13 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | -30.37% since 12/24/25 | +38.96% since 12/24/25 | +89.13% since 12/24/25 | ||
| Low | 3.19 on 03/24/26 | 1.43 on 12/30/25 | 1.31 on 12/31/25 | ||
| High | 5.10 on 12/29/25 | 2.38 on 01/16/26 | 3.95 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +1.51% since 09/25/25 | +55.07% since 09/25/25 | +75.17% since 09/25/25 | ||
| Low | 2.48 on 09/29/25 | 1.37 on 09/26/25 | 1.21 on 11/07/25 | ||
| High | 5.48 on 10/16/25 | 2.38 on 01/16/26 | 3.95 on 01/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 179,523 | 184,727 | 178,460 | ||
| Shares Outstanding, K | 55,580 | 89,240 | 72,251 | ||
| Annual Sales | 79,590,000 | 72,760,000 | 67,430,000 | ||
| Annual Net Income | -67,590,000 | 35,340,000 | -165,840,000 | ||
| Last Quarter Sales | 12,210,000 | 67,330,000 | 0 | ||
| Last Quarter Net Income | -26,320,000 | 56,850,000 | -26,690,000 | ||
| 60-Month Beta | 2.85 | 2.90 | 1.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 03/19/26 | 0.60 on 03/02/26 | -0.37 on 11/10/25 | ||
| Latest Earnings Date | 05/11/26 | 05/18/26 | 03/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.65 | 0.00 | ||